LAUSR

1. Bellapart J and Boots R. Potential use of melatonin in sleep and delirium in the critically ill. Br J Anaesth 2012; 108: 572–580. 2. Choy SW, Yeoh AC, Lee ZZ, et al. Melatonin and the prevention and management of delirium: a scoping study. Front Med 2018; 4: 242–247. 3. Zhang J-J, Meng X, Li Y, et al. Effects of melatonin on liver injuries and diseases. Int J Mol Sci 2017; 18: 673. 4. Mortezaee K and Khanlarkhani N. Melatonin application in targeting oxidative-induced liver injuries: A review. J Cell Physiol 2018; 233: 4015–4032. 5. Tavakoli M. Kidney protective effects of melatonin. J Nephropharmacol 2014; 3: 7–8. 6. Esteban-Zubero E, García-Gil FA, López-Pingarrón L, et al. Potential benefits of melatonin in organ transplantation: A review. J Endocrinol 2016; 229: R129–46. 7. Oliver N, Bohorquez H, Anders S, et al. Post-liver-transplant delirium increases mortality and length of stay. Ochsner J 2017; 17: 25–30. 8. Frisk U, Olsson J, Nylén P, et al. Low melatonin excretion during mechanical ventilation in the intensive care unit. Clin Sci (Lond Engl 1979) 2004; 107: 47–53. 9. Mundigler G, Delle-Karth G, Koreny M, et al. Impaired circadian rhythm of melatonin secretion in sedated critically ill patients with severe sepsis. Crit Care Med 2002; 30: 536–540.